SAN ANTONIO, TEXAS—Three weeks of radiotherapy rather than five — and lower overall doses of radiation — were just has as effective for treating breast cancer in the UK START trial conducted among 445
SAN ANTONIO, TEXAS—Three weeks of radiotherapy rather than five — and lower overall doses of radiation — were just has as effective for treating breast cancer in the UK START trial conducted among 4451 women with ten-year follow-up data presented at the San Antonio Breast Cancer symposium. Professor John Yarnold from the Institute of Cancer Research, Royal Marsden Hospital, near London talked about the implications of using such “hypofractionated” radiotherapy instead of the older standard schedules.
LISTEN
[audio:https://www.audiomedica.com/podcasting/oncology/121206JohnYarnoldPODCASTLoRes.mp3]
